publication venue for
- Iatrogenic comorbidity in childhood and adolescence: new insights from the use of antidepressant drugs. 2014
- Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.. 36. 2022
- Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study.. 37. 2023
- Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status". 2022
- Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's Disease. 2020
- Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets. 2014